Last updated on June 2018

Screening Anti-Fungal Exposure in Intensive Care Units


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: antifungal agent
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Age 18
  • Critically ill patients requiring ICU care
  • Receiving enteral or intravenous therapy of antifungal of interest (triazole, echinocandin, amphotericin) including prophylaxis indication and antifungal therapy started in another unit (wards, operating room) for the same infectious episode
  • Availability of suitable intravenous/intra-arterial access to facilitate sample collection
  • Written informed consent has been obtained from the patient or their next of kin (according to local regulatory statements for ethical conduct of research at each study site)

Exclusion Criteria:

  • Aged < 18 years of age
  • Pregnancy
  • Consent not obtained (according to local regulatory statements for ethical conduct of research at each study site)
  • Diagnosis with human immunodeficiency virus or hepatitis B or C or tuberculosis

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.